Metabolic-Fit / 100
Pallas Health review
Pallas Health carries both routes at once — compounded semaglutide at roughly $199 a month and tirzepatide at $299, alongside genuine FDA-approved Zepbound at $1,069, Ozempic at $1,299 and Wegovy and Mounjaro at $1,349, all cash-pay on one platform. The price is flat at every dose, answered directly in its own FAQ, and the clinician, dose adjustments, check-ins and messaging are inside that figure with no membership fee layered on. Two clinicians are named and both verify as active in the federal NPI registry, the LegitScript seal is genuine rather than a self-hosted image, and there is a real refund policy — full refund if a clinician declines you, a $5 processing fee on a qualifying cancellation. Two caveats matter for a household budget: billing lands every 12 weeks in $597 and $897 blocks rather than monthly, so the advertised per-month figures are Pallas's own averages, and the compounding pharmacy is never named. There is also no postpartum, breastfeeding or PCOS content on the site at all.
then $199/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Pallas Health at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- All 50 states + D.C. (async in 43)
- Brand-name
- Yes
How we scored Pallas Health
Every factor comes from Pallas Health's own published pricing, disclosures and oversight, and the six combine into the 65/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Reasonable oversight, though some program details aren't public.
Cost is unpredictable or sits at the premium end.
Standard support — enough to stay on track, not high-touch.
Cancellation is workable but not frictionless.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.pallashealth.co
$199 and $299 a month are Pallas's own averages; the actual billing is every twelve weeks, $597 for semaglutide and $897 for tirzepatide, after discounted first months of $139 and $179. The price does not rise with dose, there is no separate membership fee, and it is cash-pay only. All fifty states and DC, async in forty-three.
What to expect when you sign up
We walked Pallas Health's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Compounded and brand-name pricing are both published on the homepage ahead of intake
- 2Begin a visit; a US-licensed clinician determines eligibility
- 3Asynchronous in 43 of 50 states; the remaining seven require one live video visit
- 4Medication ships free, only after a clinician prescribes
What we noticed
- Billing runs on a 12-week cycle ($597 semaglutide, $897 tirzepatide); the monthly figures are Pallas's own averages
- First-month rates of $139 and $179 are genuine intro pricing, distinct from the ongoing cycle
- Price is explicitly flat across the dose ladder, answered directly in the site's own FAQ
- Two clinicians named on-site; both verified active in the federal NPI registry
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $139 → $199 | All doses (billed every 12 weeks)$139 for your first month, then $597 every 12 weeks — Pallas publishes that as a $199/mo average. Same price at every dose, and the clinician, dose adjustments, check-ins and care-team messaging are all in it. |
| Compounded tirzepatide | $179 → $299 | All doses (billed every 12 weeks)$179 for your first month, then $897 every 12 weeks, published as a $299/mo average. Flat at every dose, with provider care included. |
| Brand tirzepatide | $1069 | Zepbound (brand-name)Real FDA-approved Zepbound at a cash-pay price, on the same platform as the compounded plans. |
| Brand semaglutide | $1299 | Ozempic (brand-name)Cash-pay brand Ozempic. Not billed to insurance — Pallas is cash-pay only. |
| Brand semaglutide | $1349 | Wegovy (brand-name)Cash-pay brand Wegovy, the on-label weight-loss semaglutide. |
| Brand tirzepatide | $1349 | Mounjaro (brand-name)Cash-pay brand Mounjaro. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Pallas Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Compounded and genuine brand-name GLP-1s on one platform — Zepbound, Ozempic, Wegovy, Mounjaro all cash-pay
- Flat price at every dose, stated explicitly, with no separate membership fee
- Asynchronous care in 43 of 50 states; all 50 plus D.C. covered
- Two named clinicians, both verified active in the federal NPI registry
- Published, specific refund policy including a full refund if declined
- LegitScript certification independently confirmed as genuine
The caveats
- Billing is every 12 weeks ($597 / $897), not monthly — the per-month figures are Pallas's own averages
- The compounding pharmacy is never named
- Cash-pay only; insurance is not billed under any circumstance
- A $5 processing fee plus payment-processing costs on a qualifying cancellation refund
- Seven states still require a live video visit
- No postpartum, breastfeeding or PCOS guidance anywhere on the site
Pallas Health for mothers: our verdict
Pallas Health carries both routes at once — compounded semaglutide at roughly $199 a month and tirzepatide at $299, alongside genuine FDA-approved Zepbound at $1,069, Ozempic at $1,299 and Wegovy and Mounjaro at $1,349, all cash-pay on one platform. The price is flat at every dose, answered directly in its own FAQ, and the clinician, dose adjustments, check-ins and messaging are inside that figure with no membership fee layered on. Two clinicians are named and both verify as active in the federal NPI registry, the LegitScript seal is genuine rather than a self-hosted image, and there is a real refund policy — full refund if a clinician declines you, a $5 processing fee on a qualifying cancellation. Two caveats matter for a household budget: billing lands every 12 weeks in $597 and $897 blocks rather than monthly, so the advertised per-month figures are Pallas's own averages, and the compounding pharmacy is never named. There is also no postpartum, breastfeeding or PCOS content on the site at all. The advertised entry is $139, but the standing rate settles near $199/month — so read the headline as a starting offer, not the monthly cost.
We weigh Pallas Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Pallas Health costs, in full
- Compounded semaglutide — All doses (billed every 12 weeks): $139 to start, then $199/mo
- Compounded tirzepatide — All doses (billed every 12 weeks): $179 to start, then $299/mo
- Brand-name tirzepatide — Zepbound (brand-name): $1069/mo
- Brand-name semaglutide — Ozempic (brand-name): $1299/mo
- Brand-name semaglutide — Wegovy (brand-name): $1349/mo
- Brand-name tirzepatide — Mounjaro (brand-name): $1349/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
Pallas Health says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Pallas Health prescribes
Pallas Health prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.
Where Pallas Health fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around postpartum and breastfeeding timing, not an auto-approving quiz.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you want frictionless cancellation — read the cancellation and refund terms in the caveats above before you pay.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything Pallas Health states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Pallas Health is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers weighing compounded against FDA-approved brand products who want both available from one clinician, and who can plan around a charge that lands quarterly rather than monthly.
Alternatives to Pallas Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Pallas Health
Head-to-head & alternatives
Pallas Health, answered
- Is Pallas appropriate while breastfeeding?
- No GLP-1 is, and Pallas offers no lactation guidance of its own. What distinguishes it slightly is that it stocks the FDA-approved brand products — Wegovy, Zepbound, Ozempic, Mounjaro — which at least carry their own pregnancy and lactation labeling that a clinician can actually consult, where compounded versions have none. That is a reason to raise it with the prescribing clinician, not a reason to consider it safe. There is no postpartum or breastfeeding content anywhere on the site.
- How is the price structured, exactly?
- On a 12-week cycle rather than monthly. Compounded semaglutide is $139 for the first month and then $597 every 12 weeks; tirzepatide is $179 then $897. Pallas presents those as $199/mo and $299/mo averages, which is honest arithmetic but not how the charge arrives. Everything is inside that figure — the clinician, dose adjustments, ongoing check-ins, care-team messaging — with no separate membership fee, and the price does not rise as the dose does.
- Does it offer brand-name GLP-1s or only compounded?
- Both, which is genuinely uncommon. Cash-pay brand pricing is Zepbound $1,069/mo, Ozempic $1,299/mo, and Wegovy and Mounjaro $1,349/mo each, sitting alongside the compounded plans on the same platform. Pallas does not bill insurance at all, so those are the real out-of-pocket numbers. For anyone weighing the compounded-versus-approved question, having both routes under one provider means the decision doesn't also mean changing clinicians.
- Who actually provides the care?
- US-licensed clinicians, and unusually for this category two are named publicly: Ana Lisa Carr, MD and Kelly Tenbrink. Both were checked in the federal NPI registry rather than taken on trust — Carr is active in family medicine in Tennessee, Tenbrink in emergency medicine in Florida. The LegitScript certification the site displays is also real, confirmed against LegitScript's own domain. The gap is the pharmacy: Pallas never names the compounding facility that actually prepares the medication.
Pricing, states and verification reflect Pallas Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.